BUZZ-Dianthus Therapeutics 股价下滑，此前启动 4 亿美元股票出售计划

路透中文

Mar 10

BUZZ-Dianthus <a href="https://laohu8.com/S/LENZ">Therapeutics</a> 股价下滑，此前启动 4 亿美元股票出售计划

3月9日 - ** Dianthus Therapeutics DNTH.O宣布计划增资后，盘后股价下跌5%至75.26美元

** 该公司开始 (link) 4亿美元的股票发行，以推进临床和临床前开发活动、商业准备活动和其他目的。

** DNTH 的神经疾病药物在后期试验中显示出比预期更快的反应 (link)，周一股价大涨 21.5%，报收于 79.23 美元。

** Jefferies、TD Cowen、Evercore、Stifel、Guggenheim 和 William Blair 成为股票发行的联合账簿管理人。

** 总部位于纽约的 DNTH 拥有约 4450 万股已发行股票，市值约为 35 亿美元

** 截至收盘，股价年内累计上涨 92%

** 所有 15 位分析师均看好该股，其中 7 位给予 "强烈买入 "评级；根据 LSEG 的数据，PT 中值为 105.50 美元，高于一个月前的 66 美元。

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2618674793"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618674793\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618674793?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-10 04:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618674793","market":"hk","top_or_hot":-1,"title":"BUZZ-Dianthus Therapeutics 股价下滑，此前启动 4 亿美元股票出售计划","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Dianthus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> 股价下滑，此前启动 4 亿美元股票出售计划</title></head><body><p>\n<span>3月9日</span><span> - </span>** Dianthus Therapeutics <span>DNTH.O</span>宣布计划增资后，盘后股价下跌5%至75.26美元</p><p>** 该公司开始 (link) 4亿美元的股票发行，以推进临床和临床前开发活动、商业准备活动和其他目的。</p><p>** DNTH 的神经疾病药物在后期试验中显示出比预期更快的反应 (<span>link</span>)，周一股价大涨 21.5%，报收于 79.23 美元。</p><p>** Jefferies、TD Cowen、<a href=\"https://laohu8.com/S/EVR\">Evercore</a>、<a href=\"https://laohu8.com/S/SFB\">Stifel</a>、Guggenheim 和 William Blair 成为股票发行的联合账簿管理人。</p><p>** 总部位于纽约的 DNTH 拥有约 4450 万股已发行股票，市值约为 35 亿美元</p><p>** 截至收盘，股价年内累计上涨 92%</p><p>** 所有 15 位分析师均看好该股，其中 7 位给予 \"强烈买入 \"评级；根据 LSEG 的数据，PT 中值为 105.50 美元，高于一个月前的 66 美元。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Dianthus Therapeutics 股价下滑，此前启动 4 亿美元股票出售计划</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Dianthus Therapeutics 股价下滑，此前启动 4 亿美元股票出售计划\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-03-10 04:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Dianthus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> 股价下滑，此前启动 4 亿美元股票出售计划</title></head><body><p>\n<span>3月9日</span><span> - </span>** Dianthus Therapeutics <span>DNTH.O</span>宣布计划增资后，盘后股价下跌5%至75.26美元</p><p>** 该公司开始 (link) 4亿美元的股票发行，以推进临床和临床前开发活动、商业准备活动和其他目的。</p><p>** DNTH 的神经疾病药物在后期试验中显示出比预期更快的反应 (<span>link</span>)，周一股价大涨 21.5%，报收于 79.23 美元。</p><p>** Jefferies、TD Cowen、<a href=\"https://laohu8.com/S/EVR\">Evercore</a>、<a href=\"https://laohu8.com/S/SFB\">Stifel</a>、Guggenheim 和 William Blair 成为股票发行的联合账簿管理人。</p><p>** 总部位于纽约的 DNTH 拥有约 4450 万股已发行股票，市值约为 35 亿美元</p><p>** 截至收盘，股价年内累计上涨 92%</p><p>** 所有 15 位分析师均看好该股，其中 7 位给予 \"强烈买入 \"评级；根据 LSEG 的数据，PT 中值为 105.50 美元，高于一个月前的 66 美元。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVR","symbol_name":"Evercore","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4T3ZX1YN:1","article_id":"2618674793","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618674793","pubTimestamp":1773087819,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"3月9日 - ** Dianthus Therapeutics DNTH.O宣布计划增资后，盘后股价下跌5%至75.26美元** 该公司开始  4亿美元的股票发行，以推进临床和临床前开发活动、商业准备活动和其他目的。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"EVR":"Evercore","BK4559":"巴菲特持仓","JEF":"杰富瑞","BK4139":"生物科技","BK4127":"投资银行业与经纪业","DNTH":"Dianthus Therapeutics Inc.","SF":"Stifel Financial Corp"},"translate_title":"BUZZ-Dianthus Therapeutics stock slides after launching $400 million stock sale plan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JEF":0.9,"SF":0.9,"EVR":0.9,"DNTH":0.9},"content_text":"BUZZ-Dianthus Therapeutics 股价下滑，此前启动 4 亿美元股票出售计划\n3月9日 - ** Dianthus Therapeutics DNTH.O宣布计划增资后，盘后股价下跌5%至75.26美元** 该公司开始 (link) 4亿美元的股票发行，以推进临床和临床前开发活动、商业准备活动和其他目的。** DNTH 的神经疾病药物在后期试验中显示出比预期更快的反应 (link)，周一股价大涨 21.5%，报收于 79.23 美元。** Jefferies、TD Cowen、Evercore、Stifel、Guggenheim 和 William Blair 成为股票发行的联合账簿管理人。** 总部位于纽约的 DNTH 拥有约 4450 万股已发行股票，市值约为 35 亿美元** 截至收盘，股价年内累计上涨 92%** 所有 15 位分析师均看好该股，其中 7 位给予 \"强烈买入 \"评级；根据 LSEG 的数据，PT 中值为 105.50 美元，高于一个月前的 66 美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}